Down-regulation of mast cell activation and airway reactivity in diabetic rats: role of insulin

Cavalher-Machado S.C., de Lima W. T., Damazo A.S., de Frias Carvalho V., Martins M.A., e Silva P.M.R., Sannomiya P.

Source: Eur Respir J 2004; 24 : 552-558
Journal Issue: October
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Cavalher-Machado S.C., de Lima W. T., Damazo A.S., de Frias Carvalho V., Martins M.A., e Silva P.M.R., Sannomiya P.. Down-regulation of mast cell activation and airway reactivity in diabetic rats: role of insulin. Eur Respir J 2004; 24 : 552-558

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Study of role of insulin and insulin receptor in allergic airway inflammation of rats
Source: Eur Respir J 2005; 26: Suppl. 49, 587s
Year: 2005

Adoptive transfer of T-helper cell type 1 clones attenuates an asthmatic phenotype in mice
Source: Eur Respir J 2005; 25: 653-659
Year: 2005



Inhaled insulin does not induce immediate airway responsiveness in patients with type 1 diabetes mellitus
Source: Eur Respir J 2005; 26: Suppl. 49, 582s
Year: 2005

Distribution and degranulation of airway mast cells in normal and asthmatic subjects
Source: Eur Respir J 2002; 19: 879-885
Year: 2002



Pathophysiology of asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=84
Year: 2003

T-helper cell type-2 regulation in allergic disease
Source: Eur Respir J 2005; 26: 1119-1137
Year: 2005



Increased influx of progenitor B cell subsets in the lung with diverse levels of in-situ proliferation and activation in a murine model of allergic inflammation
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014

Increased numbers of alveolar mast cells with an altered phenotype are linked to peripheral airway remodelling in patients with allergic asthma
Source: Annual Congress 2012 - Mechanisms of asthma
Year: 2012

Effect of mast cells degranulation blockade on the inflammatory response outcome in the COPD model
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016


Modulation of inflammatory cells apoptosis induced by oral tolerance in a model of chronic allergic airway inflammation in guinea pigs
Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Year: 2005


Insulin therapy increases airway responsiveness in type 2 diabetes patients
Source: Annual Congress 2008 - Cough and airway hyperresponsiveness
Year: 2008


Treatment: how does inflammatory phenotype influence response to treatment in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007


Interferon-β augments eosinophil adhesion-inducing activity of endothelial cells
Source: Eur Respir J 2008; 32: 1540-1547
Year: 2008



In vivo allergen-activated inflammatory eosinophils reduced airway smooth muscle cells apoptosis in allergic asthma patients
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021


Increased arginase activity contributes to airway remodelling in chronic allergic asthma
Source: Eur Respir J 2011; 38: 318-328
Year: 2011



The expression of CD39 mRNA is altered in peripheral blood of patients with allergic asthma
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013

The epidermal growth factor receptor mediates allergic airway remodelling in the rat
Source: Eur Respir J 2008; 32: 1213-1223
Year: 2008



The dynamic change of IL-25 and its receptor expression during allergen challenge in asthmatic subjects
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015



Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015


Disruption of CD44 variant 6 abolished bronchial hyperresponsiveness, inflammation and mast cell myositis in a murine model of asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 217s
Year: 2006